journal article·2018-11-12Open access

Three-dimensional nanofiberous PLLA/PCL scaffold improved biochemical and molecular markers hiPS cell-derived insulin-producing islet-like cells

Naser Mobarra, Masoud Soleimani, Reza Pakzad, Seyed Ehsan Enderami, Parvin Pasalar

Abstract

Nanofibrous scaffolds are considered as a new strategy for Type 1 diabetes mellitus therapy. We used a hybrid of poly-l-lactic acid (PLLA) and polycaprolactone (PCL) as three-dimensional (3D) culture models for differentiation of human induced pluripotent stem cells (hiPSCs) to beta islet-like cluster cell compared with routine culture (2D). Morphological changes of cells were checked by microscope. mRNA endodermal SOX-17 on day 7 and pancreatic gene markers Pdx1, glucagon and Glut2 were evaluated on day 23 by qPCR. As well as, insulin and C-peptide protein expression was evaluated by immunocytochemistry staining. In addition, insulin and C-peptide secretion in various glucose concentrations was evaluated by ELISA. Light and scanning electron microscopy (SEM) microscope showed changes in induced cells. In tandem, these modifications were more evident in 3 D culture. Pdx1, Glucagon and Glut2 markers in PLLA/PCL were significantly higher in 3 D culture. In addition, qualitative immunochemistry showed that insulin and C-peptide were expressed in 2 D and 3 D culture medium. Furthermore, evaluation of insulin and C-peptide clarified that secretion of these proteins in PLLA/PCL scaffold were statistically different in 2 D and 3 D strategies. These findings suggest that functional matured induction cells on PLLA/PCL scaffold can be used for islet beta cell therapy and regenerative medicine.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pancreatic function and diabetes · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Clinical Biochemistry, School of Medicine, Mashhad University of Medical Sciences

Department of Hematology, School of Medical Sciences, Tarbiat Modares University

Department of Epidemiology, Faculty of Health, Ilam University of Medical Sciences

Departments of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences

Stem Cell Technology Research Center

Metabolic disorder Research center, Endocrinology and Metabolism, Molecular sciences institute, Tehran University of Medical Sciences

Funding

Tehran University of Medical Sciences

References (40)

Show source-provided references
1. 10.1161/JAHA.117.00765110.1161/JAHA.117.007651 ↗
2. 10.1007/s11033-014-3349-510.1007/s11033-014-3349-5 ↗
3. 10.1007/s00109-012-0923-y10.1007/s00109-012-0923-y ↗
4. 10.1089/ten.teb.2013.046210.1089/ten.teb.2013.0462 ↗
5. 10.1097/00006676-200308000-0002110.1097/00006676-200308000-00021 ↗
6. 10.1007/s00534005017110.1007/s005340050171 ↗
7. 10.1080/21691401.2018.150803110.1080/21691401.2018.1508031 ↗
8. 10.1097/00007890-200201150-0002310.1097/00007890-200201150-00023 ↗
9. 10.1016/j.biomaterials.2011.06.04810.1016/j.biomaterials.2011.06.048 ↗
10. 10.1186/s13036-017-0066-310.1186/s13036-017-0066-3 ↗
11. Mashhadikhan M, Soleimani M, Parivar K, et al. ADSCs on PLLA/PCL Hybrid nanoscaffold and gelatin modification: cytocompatibility and mechanical properties. Avicenna J Med Biotechnol. 2015;7:32–38.
12. Fazili A, Gholami S, Minaie Zangi B, et al. In vivo differentiation of mesenchymal stem cells into insulin producing cells on electrospun poly-l-lactide acid scaffolds coated with matricaria chamomilla L. oil. Cell Journal 2016;18:310–321.
13. 10.1080/21691401.2018.144346610.1080/21691401.2018.1443466 ↗
14. 10.1016/j.gene.2018.05.11510.1016/j.gene.2018.05.115 ↗
15. 10.1089/ten.tea.2010.035610.1089/ten.tea.2010.0356 ↗
16. 10.1038/aps.2011.810.1038/aps.2011.8 ↗
17. 10.1002/jbm.a.3076710.1002/jbm.a.30767 ↗
18. 10.3390/molecules20121988410.3390/molecules201219884 ↗
19. 10.1371/journal.pone.007126510.1371/journal.pone.0071265 ↗
20. 10.1007/s00125-011-2335-x10.1007/s00125-011-2335-x ↗
21. 10.1097/MED.0b013e32835bc38010.1097/MED.0b013e32835bc380 ↗
22. 10.1007/s00125-007-0634-z10.1007/s00125-007-0634-z ↗
23. 10.1002/jcp.2660610.1002/jcp.26606 ↗
24. 10.1016/j.gene.2018.05.00310.1016/j.gene.2018.05.003 ↗
25. 10.1016/j.tice.2017.07.00310.1016/j.tice.2017.07.003 ↗
26. Mobarra N, Soleimani M, Kouhkan F, et al. Efficient Differentiation of Human Induced Pluripotent Stem Cell (hiPSC) Derived Hepatocyte-Like Cells on hMSCs Feeder. Int J Hematol Oncol Stem Cell Res. 2014;8:20–29.
27. 10.1007/s12015-012-9363-x10.1007/s12015-012-9363-x ↗
28. 10.1038/cr.2009.2810.1038/cr.2009.28 ↗
29. 10.1016/j.actbio.2014.08.03610.1016/j.actbio.2014.08.036 ↗
30. 10.1002/jbm.a.3057810.1002/jbm.a.30578 ↗
31. 10.1089/ten.tea.2012.061510.1089/ten.tea.2012.0615 ↗
32. 10.1002/jbm.b.3012810.1002/jbm.b.30128 ↗
33. 10.1016/j.lfs.2016.02.04010.1016/j.lfs.2016.02.040 ↗
34. 10.1080/21691401.2017.136792810.1080/21691401.2017.1367928 ↗
35. 10.1016/j.msec.2017.02.06410.1016/j.msec.2017.02.064 ↗
36. Jaafarpour Z, Soleimani M, Hosseinkhani S, et al. Differentiation of definitive endoderm from human induced pluripotent stem cells on hmscs feeder in a defined medium. Avicenna J Med Biotechnol. 2016;8:2–8.
37. 10.1007/s11033-014-3054-410.1007/s11033-014-3054-4 ↗
38. 10.1080/21691401.2017.134592910.1080/21691401.2017.1345929 ↗
39. 10.3727/09636890978823719510.3727/096368909788237195 ↗
40. 10.2337/diabetes.49.2.23310.2337/diabetes.49.2.233 ↗